Compare, Analyse with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ZIM LABORATORIES   ADCOCK INGRAM
EQUITY SHARE DATA
    ZIM LABORATORIES
Mar-20
ADCOCK INGRAM
Jun-14
ZIM LABORATORIES/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs149365-   
Low Rs42264-   
Sales per share (Unadj.) Rs171.7108.7-  
Earnings per share (Unadj.) Rs2.0-27.4-  
Cash flow per share (Unadj.) Rs10.9-22.7-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs94.885.3-  
Shares outstanding (eoy) m16.18168.78-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.62.9 19.2%   
Avg P/E ratio x46.9-11.5 -408.0%  
P/CF ratio (eoy) x8.7-13.9 -62.9%  
Price / Book Value ratio x1.03.7 27.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,54453,081 2.9%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m5143,331 15.4%   
Avg. sales/employee Rs ThNM4,273.4-  
Avg. wages/employee Rs ThNM776.0-  
Avg. net profit/employee Rs ThNM-1,076.8-  
INCOME DATA
Net Sales Rs m2,77718,346 15.1%  
Other income Rs m45128 35.2%   
Total revenues Rs m2,82318,474 15.3%   
Gross profit Rs m226-3,179 -7.1%  
Depreciation Rs m144792 18.2%   
Interest Rs m127497 25.5%   
Profit before tax Rs m1-4,339 -0.0%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-32271 -11.9%   
Profit after tax Rs m33-4,623 -0.7%  
Gross profit margin %8.1-17.3 -47.0%  
Effective tax rate %-4,678.3-6.2 74,869.6%   
Net profit margin %1.2-25.2 -4.7%  
BALANCE SHEET DATA
Current assets Rs m1,82013,437 13.5%   
Current liabilities Rs m1,4347,560 19.0%   
Net working cap to sales %13.932.0 43.4%  
Current ratio x1.31.8 71.4%  
Inventory Days Days16111 14.7%  
Debtors Days Days89124 72.0%  
Net fixed assets Rs m1,3797,832 17.6%   
Share capital Rs m16285 190.0%   
"Free" reserves Rs m1,3730-   
Net worth Rs m1,53514,399 10.7%   
Long term debt Rs m2745,060 5.4%   
Total assets Rs m3,20027,201 11.8%  
Interest coverage x1.0-7.7 -13.0%   
Debt to equity ratio x0.20.4 50.8%  
Sales to assets ratio x0.90.7 128.7%   
Return on assets %5.0-15.2 -32.9%  
Return on equity %2.1-32.1 -6.7%  
Return on capital %7.0-19.8 -35.5%  
Exports to sales %57.60-   
Imports to sales %4.60-   
Net fx Rs m1,5690-   
CASH FLOW
From Operations Rs m2191,566 14.0%  
From Investments Rs m-191-481 39.6%  
From Financial Activity Rs m-254,592 -0.5%  
Net Cashflow Rs m105,678 0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.04 Rs / ZAR

Compare ZIM LABORATORIES With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ZIM LABORATORIES With: RPG LIFE SCIENCES  MANGALAM DRUGS  HINDUSTAN BIOSCIE  OMKAR PHARMACHEM  SUN PHARMA  



Today's Market

Sensex Ends Above 61,000-Mark, Nifty Tops 18,300; Adani Ports, Wipro & Grasim Rally 5%(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views On News

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC? (Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost (Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs... (Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Top 5 'Digital India' Stocks (Views On News)

Oct 6, 2021

These companies are leading the Government's US$1 tn 'Digital India' initiative.

5 Exciting 'Unlisted' Companies and How to Play Them (Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2022
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: How to Profit from Sensex 100,000
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

ZIM LABORATORIES SHARE PRICE


Oct 14, 2021 (Close)

TRACK ZIM LABORATORIES

  • Track your investment in ZIM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZIM LABORATORIES

ZIM LABORATORIES 5-YR ANALYSIS

COMPARE ZIM LABORATORIES WITH

FEATURED VIDEOS

How to Pick Multibagger Stocks

IRCTC: Buy, Hold or Sell

What to Look for in an IPO

My Top 4 Sectors for 2022

More Featured Videos

MARKET STATS